Convergent Validity and Test–Retest Reliability of the 1-Minute Sit-to-Stand Test Compared with the 6-Minute Walk Test in Adults with Cardiovascular Disease: A Systematic Review and Correlation Meta-Analysis
DOI:
https://doi.org/10.21831/jomassh.v2i2.2877Keywords:
1-minute sit-to-stand test, 6-minute walk test, cardiovascular disease, cardiac rehabilitation, convergent validity, correlation meta-analysis, functional capacityAbstract
Introduction: Cardiovascular disease (CVD) is the leading cause of mortality globally. The 6-Minute Walk Test (6MWT) is widely used but requires a corridor of at least 30 meters, limiting its use in telehealth and resource-limited settings. The 1-Minute Sit-to-Stand Test (1-MSTST), requiring only a standard chair and minimal space, offers a practical alternative. This study evaluated the convergent validity and test–retest reliability of the 1-MSTST versus the 6MWT in adults with CVD. Methods: Following PRISMA 2020 guidelines and registered in PROSPERO (CRD420261378362) and OSF, seven electronic databases were searched through March 2026. Eligible studies compared the 1-MSTST and 6MWT in adults with CVD. Risk of bias was assessed using COSMIN, evidence certainty using modified GRADE, and correlation coefficients were pooled via Fisher's z transformation in a random-effects model (REML estimator, Knapp–Hartung adjustment). Results: Six studies (n = 400) were included (coronary artery disease, heart failure, atrial fibrillation, pulmonary hypertension, and pulmonary arterial hypertension associated with congenital heart disease), The pooled correlation was r = 0.70 (95% CI: 0.61–0.78; I² = 60.5%), indicating moderate-to-strong convergent validity. Test–retest reliability was excellent (ICC 0.93–0.98), and two studies reported discriminative cut-offs with AUCs of 0.80–0.94. Publication-bias testing was omitted due to fewer than ten pooled studies. Conclusion: The 1-MSTST shows good convergent validity and high test–retest reliability compared with the 6MWT, supporting its use as a complementary functional assessment when the 6MWT is not feasible.
Downloads
References
1. World Health Organization. Cardiovascular diseases (CVDs) [Internet]. Geneva: WHO; 2024 [cited 2026 March 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010. https://doi.org/10.1016/j.jacc.2020.11.010
3. Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional Riskesdas 2018. Jakarta: Lembaga Penerbit Balitbangkes; 2019. Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/
4. Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1–12. doi: 10.1016/j.jacc.2015.10.044. https://doi.org/10.1016/j.jacc.2015.10.044
5. Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452–469. doi:10.1093/eurheartj/ehac747. https://doi.org/10.1093/eurheartj/ehac747
6. Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2022;19(3):180–194. doi: 10.1038/s41569-021-00611-7. https://doi.org/10.1038/s41569-021-00611-7
7. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117. https://doi.org/10.1164/ajrccm.166.1.at1102
8. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi: 10.1183/09031936.00150314. https://doi.org/10.1183/09031936.00150314
9. Beatty AL, Schiller NB, Whooley MA. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the Heart and Soul Study. Arch Intern Med. 2012;172(14):1096–1102. doi: 10.1001/archinternmed.2012.2198. https://doi.org/10.1001/archinternmed.2012.2198
10. Pepera G, Antoniou V, Karagianni E, Batalik L, Su JJ. Validity and reliability of the six-minute walking test compared to cardiopulmonary exercise test in individuals with heart failure: systematic review and meta-analysis. J Clin Med. 2025;14(23):8303. doi: 10.3390/jcm14238303. https://doi.org/10.3390/jcm14238303
11. Hwang R, Bruning J, Morris NR, Mandrusiak A, Russell T. Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure: a randomised trial. J Physiother. 2017;63(2):101–107. doi:10.1016/j.jphys.2017.02.017. https://doi.org/10.1016/j.jphys.2017.02.017
12. Ghisi GLM, Xu Z, Liu X, Mola A, Gallagher R, Babu AS, et al. Impacts of the COVID-19 pandemic on cardiac rehabilitation delivery around the world. Glob Heart. 2021;16(1):43. doi: 10.5334/gh.939. https://doi.org/10.5334/gh.939
13. Strassmann A, Steurer-Stey C, Lana KD, Zoller M, Turk AJ, Suter P, et al. Population-based reference values for the 1-min sit-to-stand test. Int J Public Health. 2013;58(6):949–953. doi: 10.1007/s00038-013-0504-z. https://doi.org/10.1007/s00038-013-0504-z
14. Crook S, Büsching G, Schultz K, Lehbert N, Jelusic D, Keusch S, et al. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J. 2017;49(3):1601871. doi: 10.1183/13993003.01871-2016. https://doi.org/10.1183/13993003.01871-2016
15. Bohannon RW, Crouch R. 1-Minute sit-to-stand test: systematic review of procedures, performance, and clinimetric properties. J Cardiopulm Rehabil Prev. 2019;39(1):2–8. doi: 10.1097/HCR.0000000000000336. https://doi.org/10.1097/HCR.0000000000000336
16. Kaur J, Sikka G, Chaudhry D. Correlation between 1-min-sit-to-stand test and 6-min walk test in patients with cardiorespiratory disorders: a brief review. Int J Res Med Sci. 2025;13(2):934–938. doi: 10.18203/2320-6012.ijrms20250283. https://doi.org/10.18203/2320-6012.ijrms20250283
17. Wang Z, Yan J, Meng S, Li J, Yu Y, Zhang T, et al. Reliability and validity of sit-to-stand test protocols in patients with coronary artery disease. Front Cardiovasc Med. 2022;9:841453. doi: 10.3389/fcvm.2022.841453. https://doi.org/10.3389/fcvm.2022.841453
18. Tanriverdi A, Ozcan Kahraman B, Ozpelit E, Savci S. Test–retest reliability and validity of 1-minute sit-to-stand test in patients with chronic heart failure. Heart Lung Circ. 2023;32(4):518–524. doi: 10.1016/j.hlc.2023.01.008. https://doi.org/10.1016/j.hlc.2023.01.008
19. Bozdemir Özel C, Yakut Özdemir H, Dural M, Al A, Yalvaç HE, Mert GÖ, et al. The one-minute sit-to-stand test is an alternative to the 6-minute walk test in patients with atrial fibrillation: a cross-sectional study and ROC curve analysis. Int J Cardiol. 2025;419:132713. doi: 10.1016/j.ijcard.2024.132713. https://doi.org/10.1016/j.ijcard.2024.132713
20. Kronberger C, et al. Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST). PLoS One. 2023;18(3):e0282697. doi: 10.1371/journal.pone.0282697. https://doi.org/10.1371/journal.pone.0282697
21. Stubbs H, Lua S, Ingram J, Jani BD, Brewis M, Church C, et al. Remote exercise testing in pulmonary hypertension (PHRET). Pulm Circ. 2023;13(4):e12325. doi: 10.1002/pul2.12325. https://doi.org/10.1002/pul2.12325
22. Pavsic N, Kacar P, Dolenc J, Prokselj K. One-minute sit-to-stand test in patients with pulmonary arterial hypertension associated with congenital heart disease: a single-center prospective study. Hellenic J Cardiol. 2024;75:41–47. doi: 10.1016/j.hjc.2023.06.006. https://doi.org/10.1016/j.hjc.2023.06.006
23. Calik Kutukcu E. The one-minute sit-to-stand test: a novel tool for assessing functional capacity in patients with atrial fibrillation [editorial]. Int J Cardiol. 2025;421:132896. doi: 10.1016/j.ijcard.2024.132896. https://doi.org/10.1016/j.ijcard.2024.132896
24. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. https://doi.org/10.1136/bmj.n71
25. Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171–1179. doi: 10.1007/s11136-017-1765-4. https://doi.org/10.1007/s11136-017-1765-4
26. Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651–657. doi: 10.1007/s11136-011-9960-1. https://doi.org/10.1007/s11136-011-9960-1
27. Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157. doi: 10.1007/s11136-018-1798-3. https://doi.org/10.1007/s11136-018-1798-3
28. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester: John Wiley & Sons; 2009. doi: 10.1002/9780470743386. https://doi.org/10.1002/9780470743386
29. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi: 10.1002/sim.1186. https://doi.org/10.1002/sim.1186
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. https://doi.org/10.1136/bmj.315.7109.629
31. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48. doi: 10.18637/jss.v036.i03. https://doi.org/10.18637/jss.v036.i03
32. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745. doi: 10.1016/j.jclinepi.2010.02.006. https://doi.org/10.1016/j.jclinepi.2010.02.006
33. Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the sit-to-stand test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med. 2007;101(2):286–293. doi: 10.1016/j.rmed.2006.05.007. https://doi.org/10.1016/j.rmed.2006.05.007
34. Reychler G, Boucard E, Peran L, Pichon R, Le Ber-Moy C, Ouksel H, et al. One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patients. Clin Respir J. 2018;12(3):1247–1256. doi: 10.1111/crj.12658. https://doi.org/10.1111/crj.12658
35. Vaidya T, de Bisschop C, Beaumont M, Ouksel H, Jean V, Dessables F, et al. Is the 1-minute sit-to-stand test a good tool for the evaluation of the impact of pulmonary rehabilitation? Determination of the minimal important difference in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2609–2616. doi: 10.2147/COPD.S115439. https://doi.org/10.2147/COPD.S115439
36. Bellet RN, Adams L, Morris NR. The 6-minute walk test in outpatient cardiac rehabilitation: validity, reliability and responsiveness—a systematic review. Physiotherapy. 2012;98(4):277–286. doi: 10.1016/j.physio.2011.11.003. https://doi.org/10.1016/j.physio.2011.11.003
37. Kronberger C, Mousavi RA, Ermolaev N, Willixhofer R, Rassoulpour N, Kaya MB, et al. One-minute sit-to-stand test cut-offs for risk stratification based on six-minute walk test thresholds in pulmonary hypertension. Eur J Prev Cardiol. 2025;32(15):1517–1524. doi:10.1093/eurjpc/zwaf031. https://doi.org/10.1093/eurjpc/zwaf031
38. Kronberger C, Mousavi RA, Ermolaev N, Poledniczek M, Schmid LM, Eslami M, et al. Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension. Sci Rep. 2026;16:6562. doi: 10.1038/s41598-026-37611-x. https://doi.org/10.1038/s41598-026-37611-x
39. Mamataz T, Uddin J, Ibn Alam S, Taylor RS, Pakosh M, Grace SL. Effects of cardiac rehabilitation in low- and middle-income countries: a systematic review and meta-analysis of randomised controlled trials. Prog Cardiovasc Dis. 2022;70:119–174. doi: 10.1016/j.pcad.2021.07.004. https://doi.org/10.1016/j.pcad.2021.07.004
40. Ragupathi L, Stribling J, Yakunina Y, Fuster V, McLaughlin MA, Vedanthan R. Availability, use, and barriers to cardiac rehabilitation in LMIC. Glob Heart. 2017;12(4):323–334.e10. doi: 10.1016/j.gheart.2016.09.004. https://doi.org/10.1016/j.gheart.2016.09.004
41. Triangto I, Dhamayanti AS, Putra MS, Witjaksono D, Rahmad, Zuhriyah L, et al. Correlation of sit-to-stand test and 6-minute walk test to illustrate cardiorespiratory fitness in systolic heart failure patients. Ann Rehabil Med. 2025;49(1):23–29. doi: 10.5535/arm.240057. https://doi.org/10.5535/arm.240057
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2026 Asma' Kamila, Ikhlasul, Khoironnisai
This work is licensed under a Creative Commons Attribution 4.0 International License.
